OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Indoco Remedies OCF Yield % Related Terms
Indoco Remedies OCF Yield % Historical Data
* Premium members only.
The historical data trend for Indoco Remedies's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Indoco Remedies's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indoco Remedies OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Indoco Remedies's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Indoco Remedies's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indoco Remedies (NSE:INDOCO) has a OCF Yield % of 10.04 as of Jul. 07, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Indoco Remedies and its competitors. Over the past decade, Indoco Remedies' OCF Yield % has ranged from 10.04 to 10.04. According to the industry distribution chart, Indoco Remedies ranks #204 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 20.3%.
Is Indoco Remedies' OCF Yield % too high?
Indoco Remedies' current OCF Yield % is 10.04. Over the past 10 years, this metric has ranged from a low of 10.04 to a high of 10.04. The Drug Manufacturers industry median OCF Yield % is 3.51. Indoco Remedies' value of 10.04 is 186% above this industry median. Based on the distribution chart, Indoco Remedies ranks #204 out of 1007 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Indoco Remedies has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indoco Remedies' OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Indoco Remedies ranks #204 out of 1007 companies for OCF Yield %. This places Indoco Remedies in the top 20% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.51. Indoco Remedies' value of 10.04 is 186% above this benchmark. Historically, Indoco Remedies' own OCF Yield % has ranged from 10.04 to 10.04 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.51, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indoco Remedies's current OCF Yield % of 10.04 is 186% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Indoco Remedies and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indoco Remedies's current OCF Yield % is 10.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indoco Remedies stock overvalued right now?
Based on GuruFocus' analysis, Indoco Remedies (NSE:INDOCO) is currently considered Possible Value Trap. The stock's GF Value™ is ₹358.67, compared to a current price of ₹235.64 — trading 34.3% below its estimated fair value. The current OCF Yield % is 10.04 and 186% above the Drug Manufacturers industry median of 3.51. Indoco Remedies' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Indoco Remedies (NSE:INDOCO), the current OCF Yield % is 10.04 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indoco Remedies (NSE:INDOCO) Overvalued in 2026?
Based on GuruFocus' analysis, Indoco Remedies stock appears to be undervalued.
The current stock price of ₹235.64 is trading 34.3% below its estimated GF Value™ of ₹358.67.
GuruFocus considers Indoco Remedies to be Possible Value Trap.
Key valuation signals for NSE:INDOCO:
OCF Yield %: 10.04
GF Value™: ₹358.67 vs. price of ₹235.64 (34.3% below fair value)
Industry Position: 186% above the Drug Manufacturers median (#204 of 1007)
No single metric tells the full story. See the NSE:INDOCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.
71GF Score
Get the complete analysis for NSE:INDOCO
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOCO has been successfully added to your 
